These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28965431)

  • 1. Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3.
    Schaller TH; Batich KA; Suryadevara CM; Desai R; Sampson JH
    Expert Rev Clin Immunol; 2017 Nov; 13(11):1049-1060. PubMed ID: 28965431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells.
    Drakes ML; Zahorchak AF; Takayama T; Lu L; Thomson AW
    Transpl Immunol; 2000 Mar; 8(1):17-29. PubMed ID: 10834607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3 Signaling in the Tumor Microenvironment.
    Ntanasis-Stathopoulos I; Fotiou D; Terpos E
    Adv Exp Med Biol; 2020; 1231():13-21. PubMed ID: 32060842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors.
    Walsh MP; Duncan B; Larabee S; Krauss A; Davis JP; Cui Y; Kim SY; Guimond M; Bachovchin W; Fry TJ
    PLoS One; 2013; 8(3):e58860. PubMed ID: 23554941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-based immunotherapy: a basic review and recent advances.
    Constantino J; Gomes C; Falcão A; Neves BM; Cruz MT
    Immunol Res; 2017 Aug; 65(4):798-810. PubMed ID: 28660480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines.
    Gouwy M; De Buck M; Pörtner N; Opdenakker G; Proost P; Struyf S; Van Damme J
    Eur J Immunol; 2015 Jan; 45(1):101-12. PubMed ID: 25345597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.
    Castellino F; Huang AY; Altan-Bonnet G; Stoll S; Scheinecker C; Germain RN
    Nature; 2006 Apr; 440(7086):890-5. PubMed ID: 16612374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.
    Wen Y; Wang H; Wu H; Yang F; Tripp RA; Hogan RJ; Fu ZF
    J Virol; 2011 Feb; 85(4):1634-44. PubMed ID: 21106736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
    Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
    Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.
    Saxena M; Bhardwaj N
    Curr Opin Immunol; 2017 Aug; 47():35-43. PubMed ID: 28732279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
    Dieu MC; Vanbervliet B; Vicari A; Bridon JM; Oldham E; Aït-Yahia S; Brière F; Zlotnik A; Lebecque S; Caux C
    J Exp Med; 1998 Jul; 188(2):373-86. PubMed ID: 9670049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunotherapy of cancer: an overview and future directions.
    Tao Z; Li S; Ichim TE; Yang J; Riordan N; Yenugonda V; Babic I; Kesari S
    Immunotherapy; 2017 Jun; 9(7):589-606. PubMed ID: 28595516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.
    Morisaki T; Matsumoto K; Onishi H; Kuroki H; Baba E; Tasaki A; Kubo M; Nakamura M; Inaba S; Yamaguchi K; Tanaka M; Katano M
    Hum Cell; 2003 Dec; 16(4):175-82. PubMed ID: 15147037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG-independent synergistic induction of beta-chemokines and a dendritic cell phenotype by orthophosphorothioate oligodeoxynucleotides and granulocyte-macrophage colony-stimulating factor in elutriated human primary monocytes.
    Wang J; Alvarez R; Roderiquez G; Guan E; Caldwell Q; Wang J; Phelan M; Norcross MA
    J Immunol; 2005 May; 174(10):6113-21. PubMed ID: 15879106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANTES-induced chemokine cascade in dendritic cells.
    Fischer FR; Luo Y; Luo M; Santambrogio L; Dorf ME
    J Immunol; 2001 Aug; 167(3):1637-43. PubMed ID: 11466387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.
    Fu Q; Wu Y; Yan F; Wang N; Wang W; Cao X; Wang Y; Wan T
    Cell Mol Immunol; 2011 Sep; 8(5):424-32. PubMed ID: 21785448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving homing in T cell therapy.
    Vignali D; Kallikourdis M
    Cytokine Growth Factor Rev; 2017 Aug; 36():107-116. PubMed ID: 28690108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.